Every three minutes, someone in the U.S. is diagnosed with a blood cancer and right now more than 1.1 million people in the U.S. are living with, or in remission from, a blood cancer. Unlike with other cancers, you cannot screen or prevent for most blood cancers. But thanks to breakthrough research, survival rates for patients with many blood cancers have doubled, tripled and even quadrupled since the early 1960s.
Since its inception 65 years ago, The Leukemia & Lymphoma Society (LLS) has invested more than $1 billion to advance cancer therapies and save lives. In that time, cures for many patients with acute lyphoblastic leukemia (ALL) and Hodgkin lymphoma have been achieved and the five-year survival rate for children with ALL jumped from 3 percent in 1964 to approximately 90 percent in 2014.
Check out this episode of the Health Tech Weekly Podcast where host Jamie Davis, the Podmedic interviews Dr. Louis DeGennaro, Ph.D. president and CEO of the LLS, and LLS Ambassador Jessica Melore who is herself a cancer survivor. They talk about Blood Cancer Awareness Month in September and some of the key advancements and new treatments being pioneered by the LLS.
Subscribe – Health Tech Weekly Show
That will wrap up this episode of Health Tech Weekly. Make sure you follow up over at our website, HTWeekly.com, for more information on this and all of our episodes. There are additional resource links, links to trusted resources for living a healthier lifestyle and more. If you have a comment on this week’s episode please get back in touch with me either over at HTWeekly.com in comment links for each article or shoot me an email at email@example.com.